Anexsia
Company: Mallinckrodt Group
Approval Status: Approved August 1996
Treatment for: chronic pain
Areas: Neurology; Oncology
General Information
Other Useful Resources
Anexsia has been approved for the treatment of chronic pain. Anexsia is a new dosage strength of medication combining the pain relievers acetaminophen and hydrocodone, an opiate-based narcotic. This new dosage will be the strongest combination of these two analgesics on the market. Anexsia is taken orally and is used to treat moderate to moderately severe pain.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
